We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolution Group PLS Regulatory News (FAN)

Share Price Information for Volution Group PLS (FAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 414.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.486%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 414.00
FAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

5 Jun 2020 07:00

RNS Number : 0342P
Volution Group plc
05 June 2020
 

 

Embargoed to 07:00

Friday 5 June 2020

 

 

Volution Group plc

 

Trading Update

 

 

 

Overview

 

Further to the announcements of 25th March and 2nd April, Volution Group plc ("Volution" or "the Group" or "the Company", LSE: FAN), a leading supplier of ventilation products to the residential and commercial construction markets in the UK, Continental Europe and Australasia, today provides an update on trading and progress with respect to managing the impact on the business of COVID-19.

 

Since the announcement of 2nd April:

 

·

Trading outside of the U.K. (52% of FY19 Group revenues) has been robust, with May at around 91% of prior year levels;

 

·

All of our facilities including those in the U.K. are operational; U.K. activity levels remain subdued but have picked up from 30% of prior year levels in April to 42% in May, with a further step up so far in June;

 

·

We have seen continued, good cash generation, with cash in bank and on deposit increasing from £41 million as at 31st March to £49 million as at 31st May. Our undrawn facilities under the Group's £120 million Revolving Credit Facility remain unchanged;

 

·

Discretionary cost and capital expenditure continues to be tightly managed, with ongoing investment focused on key new product developments;

 

·

The Board, including the Executive Directors, will extend the period of their 20% salary reduction until the end of the financial year on the 31st July; and

 

·

As at 1st June, 46% of our U.K. workforce was on furlough, compared to 65% at its peak, and we will continue to bring staff back as demand returns.

 

Looking after our people

 

The safety and wellbeing of our employees is of paramount importance. We have worked carefully across all of our facilities, drawing on the expertise of both our operational leaders and external occupational health specialists, to ensure that we adhere to all workplace regulations announced by the Governments of the countries we operate in. We have implemented additional measures to assist employees navigate this challenging period, including the provision of wellbeing advice and guidance, support via an Employee Assistance Programme, and use of posters, videos and a "first-day induction" to help people safely return to our sites where appropriate.

 

Trading

 

Our non-UK revenues have been resilient across all of our markets. Our Nordics and German businesses have continued to operate at good revenue levels. With additional pick-up in activity in Belgium, and the resumption of operations in New Zealand enabled by the relaxation of restrictions since late April, May revenues in both our Continental Europe and Australasian segments are running at between 90-95% of prior year levels.

 

In the U.K. our activity has improved from approximately 30% of prior year levels in April, to 42% in May and already are at approximately 65% in early June trading. Return to construction sites by house-builders and the re-starting of commercial projects has enabled our new build residential and commercial sectors to start recovering but at a slow pace, whilst in the RMI category we are seeing public housing most impacted due to restrictions and inability of contractors to access customer properties. 

 

Our "capex and overhead light" operating model and strong working capital disciplines has ensured that the Group has continued to generate positive operating cash flows since the start of the pandemic. Whilst the crisis has reduced revenues through April and May, our asset light model gives us considerable flexibility and resilience to withstand the current downturn in activity.

 

Operational excellence

 

During the period, we have continued with our ongoing operational improvement programme. The Company has made a number of ERP platform investments in recent years to facilitate consistency and efficiency across our businesses. The most recent stage of this programme has focussed on streamlining process across certain parts of the Group which regrettably will result in a small number of job losses, predominantly in the U.K. Going forward, we will use this period of lower activity to drive forward our initiatives regarding the cross-selling of our different products.

 

Ronnie George, Volution Chief Executive, commented:

 

"As with many businesses, COVID-19 has had an adverse impact across our Group with the U.K. most notably affected. However, we have benefitted from our geographic diversity which has helped partially insulate the overall Group as other countries remained more active and are emerging from lock down more quickly.

 

Since the latter stages of March, when the various country lock downs started to have an impact, I have been truly impressed with the speed and agility with which our local teams moved the organisational support to remote working and our production and warehouse facilities to be COVID-19 safe. Our committed employees, led by the local management teams have done an amazing job to keep our facilities safe, secure and productive and continued to supply essential ventilation equipment to our customers. I am particularly proud of the support we provided in supplying ventilation equipment to a number of quickly erected "Nightingale Hospitals" in the U.K., notably the substantial effort at the Excel centre in London.

 

There is an increasing awareness, and body of research, demonstrating that efficient and well ventilated buildings are essential for health and wellbeing and have a key role to play in governmental strategies to reduce the future risks from COVID-19 and other viruses. As such, we remain certain that increased awareness of the link between air quality and health, coupled with long term regulatory and consumer trends that underpin our markets will continue to increase the demand for our solutions."

 

Outlook

 

The unprecedented uncertainty around the impact of COVID-19, means it continues to be difficult to assess with certainty our near-term financial performance, particularly in the U.K., although we do remain encouraged by the robustness of activity levels in our Continental European and Australasian markets.

 

A further update will be provided in late July in a pre-close trading statement.

 

-Ends-

 

Enquiries:

 

 

Volution Group plc

 

Ronnie George, Chief Executive Officer

+44 (0) 1293 441501

Andy O'Brien, Chief Financial Officer

+44 (0) 1293 441536

 

 

Liberum Capital Limited

+44 (0) 203 100 2222

Neil Patel

 

Richard Bootle

 

Edward Phillips

 

 

 

Tulchan Communications

+44 (0) 207 353 4200

James Macey White

 

David Allchurch

 

Giles Kernick

 

 

Legal Entity Identifier: 213800EPT84EQCDHO768.

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) prior to its release as part of this announcement.

 

Note to Editors:

 

Volution Group plc (LSE: FAN) is a leading supplier of ventilation systems and products to both the residential and commercial construction markets in the UK, Continental Europe and Australasia.

 

Volution Group comprises 16 key brands across the three regions:

 

UK: Vent-Axia, Manrose, Diffusion, National Ventilation, Airtech, Breathing Buildings, Torin-Sifan.

Continental Europe: Fresh, PAX, VoltAir, Kair, Air Connection, inVENTer, Ventilair.

Australasia: Simx, Ventair.

 

For more information, please go to: www.volutiongroupplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKQBBABKDKAK
Date   Source Headline
16th Apr 20247:00 amRNSAppointment of Joint Corporate Broker
2nd Apr 202410:00 amRNSTotal Voting Rights
2nd Apr 20249:46 amRNSHolding(s) in Company
27th Mar 20244:15 pmRNSShare Purchase by Chairman
19th Mar 20249:00 amRNSHolding(s) in Company
15th Mar 20247:00 amRNSHalf Year Results
26th Feb 202411:30 amRNSNotice of Interim Results
10th Jan 20249:45 amRNSDirector Declaration
8th Jan 202412:00 pmRNSHolding(s) in Company
13th Dec 20232:00 pmRNSResults of AGM
13th Dec 20237:00 amRNSAGM Trading Update
11th Dec 20233:30 pmRNSAuditor Resignation
1st Dec 20232:00 pmRNSTotal Voting Rights
15th Nov 20234:45 pmRNSDirector/PDMR Shareholding
1st Nov 20234:15 pmRNSTotal Voting Rights
23rd Oct 20234:00 pmRNSDirector/PDMR Shareholding
19th Oct 20233:35 pmRNSAnnual Report 2023 & Notice of AGM
13th Oct 20234:30 pmRNSDirector/PDMR Shareholding
12th Oct 202312:20 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSPreliminary Results for year ended 31 July 2023
3rd Oct 20236:15 pmRNSTotal Voting Rights
23rd Aug 20233:53 pmRNSHolding(s) in Company
16th Aug 20235:22 pmRNSHolding(s) in Company
1st Aug 20234:00 pmRNSTotal Voting Rights
20th Jul 20237:00 amRNSPre-close Trading Update
17th Jul 202310:00 amRNSNotice of Pre-close Trading Update
3rd Jul 20235:15 pmRNSTotal Voting Rights
27th Jun 20235:00 pmRNSHolding(s) in Company
23rd Jun 20237:00 amRNSCompletion of Acquisition
19th Jun 20239:00 amRNSBoard Appointment
1st Jun 20234:30 pmRNSTotal Voting Rights
31st May 20231:30 pmRNSDirector Declaration
20th Apr 20237:00 amRNSAcquisitions Announcement
3rd Apr 202312:15 pmRNSTotal Voting Rights
15th Mar 20234:20 pmRNSHolding(s) in Company
15th Mar 20231:36 pmRNSAppointment of Chair Designate
9th Mar 20237:00 amRNSHalf year Results
8th Mar 20233:50 pmRNSDirectorate Change
1st Mar 20234:30 pmRNSTotal Voting Rights
20th Feb 20231:00 pmRNSNotice of Interim Results
1st Feb 20234:00 pmRNSTotal Voting Rights
1st Feb 20233:45 pmRNSChange of Auditor
3rd Jan 20234:30 pmRNSTotal Voting Rights
14th Dec 20224:05 pmRNSResults of AGM
14th Dec 20227:00 amRNSAGM Trading Update
13th Dec 20223:00 pmRNSHolding(s) in Company
1st Dec 20224:05 pmRNSTotal Voting Rights
1st Nov 20224:00 pmRNSTotal Voting Rights
26th Oct 20228:45 amRNSDirector Declaration
21st Oct 20223:30 pmRNSAnnual Report 2022 & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.